Home Cart 0 Sign in  

[ CAS No. 51-52-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 51-52-5
Chemical Structure| 51-52-5
Structure of 51-52-5 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 51-52-5 ]

Related Doc. of [ 51-52-5 ]

Alternatived Products of [ 51-52-5 ]

Product Details of [ 51-52-5 ]

CAS No. :51-52-5 MDL No. :MFCD00006041
Formula : C7H10N2OS Boiling Point : -
Linear Structure Formula :- InChI Key :KNAHARQHSZJURB-UHFFFAOYSA-N
M.W : 170.23 Pubchem ID :657298
Synonyms :
6-n-Propylthiouracil;6-Propyl-2-thiouracil;CTK8G2614;6-(Propyl-d5)-2-thiouracil;Propycil-d5;Propacil-d5;Procasil-d5;Propylthiouracil-d5;NSC 70461;NSC 6498;PTU

Calculated chemistry of [ 51-52-5 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.43
Num. rotatable bonds : 2
Num. H-bond acceptors : 1.0
Num. H-bond donors : 2.0
Molar Refractivity : 46.83
TPSA : 80.74 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.78 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.63
Log Po/w (XLOGP3) : 0.79
Log Po/w (WLOGP) : 1.39
Log Po/w (MLOGP) : 0.38
Log Po/w (SILICOS-IT) : 3.68
Consensus Log Po/w : 1.57

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.66
Solubility : 3.68 mg/ml ; 0.0216 mol/l
Class : Very soluble
Log S (Ali) : -2.07
Solubility : 1.46 mg/ml ; 0.00858 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.86
Solubility : 0.234 mg/ml ; 0.00138 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.13

Safety of [ 51-52-5 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335-H351-H361 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 51-52-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 51-52-5 ]
  • Downstream synthetic route of [ 51-52-5 ]

[ 51-52-5 ] Synthesis Path-Upstream   1~2

  • 1
  • [ 17356-08-0 ]
  • [ 30414-54-1 ]
  • [ 51-52-5 ]
YieldReaction ConditionsOperation in experiment
78% With potassium carbonate In water at 70 - 105℃; for 3 h; 3-Oxohexanoic acid methyl ester (1) (2.95 ml_, 20.81 mmol) and K2CO3 (2.819 g, 20,39 mmol) were added to a solution of thiourea (1.044 g, 13.73 mmol) in water (1.8 ml_) at 700C. The obtained mixture was stirred at 1050C for 3 hours, cooled to room temperature and diluted with water (7,5 mi_). Thereafter, concentrated aqueous HCI solution (6.75 ml_) was added carefully. The resulting precipitate was collected by filtration, washed with water and dried, giving compound 2 as a white-yellow solid. Yield 1.815 g, 78percent. MW 170.23. LCMS tR (min): 1.17. MS (APCI+), m/z 171.12 [M-t-hTf.
Reference: [1] Patent: WO2010/118367, 2010, A2, . Location in patent: Page/Page column 51
[2] Journal of Enzyme Inhibition and Medicinal Chemistry, 2016, vol. 31, # 6, p. 1362 - 1368
[3] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 23, p. 7180 - 7184
  • 2
  • [ 3249-68-1 ]
  • [ 17356-08-0 ]
  • [ 51-52-5 ]
Reference: [1] RSC Advances, 2017, vol. 7, # 28, p. 17427 - 17441
[2] Journal of the American Chemical Society, 1945, vol. 67, p. 2197,2200
[3] Bulletin des Societes Chimiques Belges, 1950, vol. 59, p. 689
[4] Zhurnal Obshchei Khimii, 1951, vol. 21, p. 760,762;engl.Ausg.S.837,839
[5] European Journal of Medicinal Chemistry, 1988, vol. 23, # 1, p. 53 - 62
[6] Acta Chemica Scandinavica, 1996, vol. 50, # 5, p. 417 - 421
[7] Medicinal Chemistry Research, 2013, vol. 22, # 10, p. 5036 - 5043
Same Skeleton Products
Historical Records